Loading
CP
Computer Programs & Systems Inc Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Pinetree Capital Ltd., was filed 03 Dec 2025.
Computer Programs & Systems Inc: what insiders have been doing
This page follows insider dealings at Computer Programs & Systems Inc as filed with SEC (Form 4), a company from the Healthcare & Pharma sector. Between 18 October 2025 and 18 October 2026, 17 insiders published 54 filings.
No insider sold shares on the market over the period. Instead, the filings list 4 purchases totalling €2.2M, made by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €1.4M from Pinetree Capital Ltd., disclosed on 3 December 2025. Among those who bought: 1 senior executive.
In the case of 3 purchases, another manager of the company was buying within the same 30 days. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. The most recent open-market purchase was published on 3 December 2025, 322 days ago. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4.
With 54 filings in twelve months, the company is more active than the median of 22 filings across the 5,458 companies we follow on the same exchange. Since 2016, the database holds 19 purchases and 77 sales by insiders of the company. For the fiscal year to 31 December 2025, the annual 10-K puts revenue at 346.8 m USD and net income at 4.4 m USD.
Elsewhere in the same sector, our signals recently picked up insider purchases at Anixa Biosciences Inc and Vivos Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Insider Decl.
256
Thresholds
n/a
Buy Volume
€9M
19 ops. · all time
Sell Volume
€3M
77 ops. · all time
Who traded when
BuySalePinetree Capital Ltd.5 buys
L6 Holdings Inc.3 buys
Christopher L. Fowler2 sales
David Harse1 sale
Mark Anquillare V1 buy
Michael Daughton1 buy
+1 other insider
Since the insiders bought
- +2.2%Entry 28.70 · Close at T+90 29.34
- +8.1%Entry 26.88 · Close at T+90 29.06
- +295.5%Entry 10.04 · Close at T+365 39.71
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Financial data
as of FY 2025FY ended December 2025 · cache
Income statement
Revenue309.3M
Gross profit137.7M45% margin
Net income3.9M1.3% margin
Last declaration on 10 July 2026
Declarations256 total
21,554 shares@ US$26.250.034% mcap92.5% of flowCommon StockSEC:0001472710-26-000002:0
4,376 shares@ US$26.250.0070% mcap100.0% of flowCommon StockSEC:0002057313-26-000002:0
46,800 shares@ US$26.250.075% mcap36.8% of flowCommon StockSEC:0001215657-26-000006:3
59,315 shares@ US$26.250.095% mcap84.0% of flowCommon StockSEC:0002089896-26-000004:1
120,486 shares@ US$26.250.19% mcap84.1% of flowCommon StockSEC:0001454872-26-000008:1
16 shares@ US$26.250.0000% mcap0.0% of flowCommon StockSEC:0001454872-26-000008:2
31,591 shares@ US$26.250.050% mcap100.0% of flowCommon StockSEC:0001209174-26-000002:0
16,888 shares@ US$26.250.027% mcap81.7% of flowCommon StockSEC:0002056774-26-000008:1
2,130,000 shares@ US$26.253.40% mcap67.2% of flowCommon stock, par value $0.001 per share ("Common Stock")SEC:0000921895-26-001794:0
2,130,000 shares@ US$26.253.40% mcap71.5% of flowCommon stock, par value $0.001 per share ("Common Stock")SEC:0000921895-26-001793:0
850,000 shares@ US$26.251.36% mcap28.5% of flowCommon StockSEC:0000921895-26-001793:1
12,460 shares@ US$26.250.020% mcap88.0% of flowCommon StockSEC:0001969742-26-000008:1
50,687 shares@ US$26.250.081% mcap93.8% of flowCommon StockSEC:0001087064-26-000002:0
38,687 shares@ US$26.250.062% mcap100.0% of flowCommon StockSEC:0001594511-26-000002:0
1,934 shares@ US$26.250.0031% mcap72.9% of flowCommon StockSEC:0002017697-26-000009:1
7,734 shares@ US$26.250.012% mcap95.1% of flowCommon StockSEC:0002057320-26-000006:1
10,507 shares0Common StockSEC:0002008131-26-000006:0
1,990 shares@ US$28.311.7% of flowCommon StockSEC:0001215657-26-000006:0
2,793 shares@ US$28.102.4% of flowCommon StockSEC:0001215657-26-000006:1
8,749 shares0Common StockSEC:0002089896-26-000004:0
16,286 shares0Common StockSEC:0001454872-26-000008:0
4,203 shares0Common StockSEC:0002056774-26-000008:0
2,150 shares0Common StockSEC:0001969742-26-000008:0
753 shares0Common StockSEC:0002017697-26-000009:0
4,308 shares0Common StockSEC:0002057320-26-000006:0
25 of 256 declarations
About Computer Programs & Systems Inc
COMPUTER PROGRAMS & SYSTEMS INC. (CPSI) is a U.S.-based healthcare technology company listed on the NASDAQ market in the United States. For investors, CPSI is best understood as a specialized provider of software and services for community hospitals, affiliated clinics, and other healthcare organizations that need to modernize both clinical and administrative workflows. The company was founded in 1979 and has built its business around healthcare information technology, patient data management, and the optimization of billing and collections processes. Its headquarters are in Mobile, Alabama, United States.
CPSI’s business model combines several complementary operating lines. It offers electronic health record and hospital management solutions for acute care settings, software and services for post-acute care providers, and a broad set of revenue cycle management, consulting, and managed IT services. It also provides patient engagement tools and medical coding software, allowing it to participate across a large part of the healthcare workflow, from patient intake and clinical documentation to reimbursement and back-office administration. This “software plus services” model is particularly relevant in the U.S. healthcare market, where many small and mid-sized providers prefer integrated platforms over standalone point solutions.
Read moreShow less
From a competitive standpoint, CPSI operates in a market dominated by larger healthcare software vendors and specialized revenue-cycle and outsourced-services providers. Its differentiation lies in its focus on community hospitals and mid-market healthcare organizations, the breadth of its installed base, and its ability to bundle clinical software with administrative and financial services. That positioning can be attractive because it creates customer stickiness and recurring revenue opportunities, but it also exposes the company to contract renewal risk, implementation execution risk, reimbursement pressure, and cybersecurity and regulatory scrutiny.
Geographically, CPSI remains primarily focused on the United States, although certain services and customer relationships may extend beyond domestic operations depending on the business line and engagement structure. Recent highlights include ongoing portfolio reshaping around healthcare technology and services, along with corporate actions and governance-related disclosures that the market has followed closely. The company also regularly files SEC disclosures, including Form 4 insider transaction reports, which makes it a name that can attract event-driven and value-oriented investors.
Overall, CPSI is a specialized U.S. healthcare IT and services company with a smaller-cap profile and a clear niche. Its investment case depends on operational execution, recurring revenue quality, and its ability to defend and expand its position among community healthcare providers in a highly competitive and rapidly evolving market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
